Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus

Journal of Endocrinology

Volumn 170, Issue 3, 2001, Pages 555-564

  Green, A R ^a   Parrott, E L ^a   Butterworth, M ^a   Jones, P S ^a   Greaves, P ^a   White, I N H ^a  

^a Centre Mechanisms of Human Toxicity   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; COMPLEMENTARY DNA; CREATINE KINASE BB; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA2; HEAT SHOCK PROTEIN 27; ORNITHINE DECARBOXYLASE; RALOXIFENE; RETINOBLASTOMA PROTEIN; SECRETIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TELOMERASE; TOREMIFENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG EFFICACY; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROBLASTOMA; NONHUMAN; OVARIECTOMY; PHASE TRANSITION; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR SUPPRESSOR GENE; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL CULTURE TECHNIQUES; CREATINE KINASE; CREATINE KINASE, BB FORM; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; ISOENZYMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORNITHINE DECARBOXYLASE; OVARIECTOMY; RALOXIFENE; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TOREMIFENE; UTERUS;

EID: 0034836963     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1700555     Document Type: Article

References (43)

1. In situ hybridisation for creatine kinase-B messenger RNA in rat uterus and brain
2. Oestrogen- and antioestrogen-induced ornithine decarboxylase activity and uterine growth in the rat
3. Histochemical studies with an estrogen receptor-related protein in human breast tumours
4. 32P-postlabelling in three rat strains exposed to dietary tamoxifen: The relationship between cell proliferation and liver tumour formation
5. Compartmentalized uterotrophic effects of tamoxifen, toremifene, and estradiol in the ovariectomised Wistar (Han) rat
6. Modulation of secretin release by neuropeptides in secretin-producing cells
7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
8. Tamoxifen for early breast cancer: An overview of the randomised trials
9. The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial
10. Heat-shock protein 27 (HSP27) and its role in female reproductive organs
11. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
12. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
13. Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1:CD(BR) rats
14. Hormonal control of ornithine decarboxylase and spermidine/spermine N1-acetyl-transferase activates by sex steroid hormones in the uterus of ovariectomised rats
15. Statistical analysis of array expression data as applied to the problem of tamoxifen resistance
16. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer
17. Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent
18. Multiple regulation of ornithine decarboxylase in enzyme-overproducing cells
19. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression
20. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
21. Estrogen activates telomerase
22. The key to the antiestrogen mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor
23. Protein measurement with the Folin phenol reagent
24. Differential response of individual uterine cell types from immature rats treated with estradiol
25. The postnatal ontogeny of rat uterine ornithine decarboxylase: Acquisition of a second peak of estrogen-induced enzyme activity
26. Identification of estrogen receptor beta(2), a functional variant of estrogen receptor beta expressed in normal rat tissues
27. Synergism between a half-site and an imperfect oestrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene
28. Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antioestrogen therapy in postmenopausal women with breast cancer
29. Chicken ovalbumin upstream promoter-transcription factors and their regulation
30. Estrogen increases adrenergic- but not cholinergic-mediated production of inositol phosphates in rabbit uterus
31. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen
32. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
33. Expression of oestrogen receptor beta (ERbeta) in multiple rat tissues visualised by immunohistochemistry
34. Expression of the Wilms' tumour suppressor gene, WT1, reduces the tumourigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice
35. Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo
36. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats
37. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta
38. 3-ions
39. The tamoxifen dilemma
40. Genotoxic potential of tamoxifen and analogues in female Fischer F344/N rats, DBA/2 and C57B1/6 mice and in human MCL-5 cells
41. Structural organization and expression of the mouse estrogen receptor
42. Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene
43. Exit for G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSw1/SNF and Rb-hSW1/SNF